Appili Therapeutics Inc. APLI.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.39M | -3.07M | -2.15M | -1.84M | -1.66M |
| Total Depreciation and Amortization | 4.30K | 5.90K | 7.20K | 10.10K | 9.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 779.10K | 578.70K | 943.30K | 1.40M | 1.79M |
| Change in Net Operating Assets | 1.62M | 1.52M | 1.16M | 273.70K | 565.70K |
| Cash from Operations | -991.40K | -969.30K | -36.00K | -151.30K | 699.90K |
| Capital Expenditure | -- | -- | 0.00 | -500.00 | -1.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -500.00 | -1.70K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -32.60K | -57.40K | -104.90K | -131.90K | -128.40K |
| Issuance of Common Stock | 277.50K | 277.50K | 177.50K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 119.10K | -68.90K | -104.10K | -89.70K | -58.70K |
| Cash from Financing | 262.70K | 108.90K | -22.20K | -158.40K | -133.70K |
| Foreign Exchange rate Adjustments | 13.10K | -1.10K | 48.60K | 55.90K | 11.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -715.80K | -861.70K | -9.70K | -254.40K | 576.10K |